Table 1. Demographic and clinical characteristics of the ALS patients and HCs.
| Variables | ALS (n = 54) | HC (n = 54) | p value |
|---|---|---|---|
| Gender (female/male) | 18/36 | 18/36 | 1a |
| Age (years) | 48.71 ± 10.21 | 48.30 ± 8.74 | 0.82b |
| Gray matter | 649.56 ± 2842.17 | 668.23 ± 3251.82 | 0.08b |
| Disease duration (months) | 20.93 ± 21.56 | – | – |
| ALSFRS-R | 32.56 ± 6.83 | – | – |
| Disease progression rate | 1.28 ± 1.15 | – | – |
Notes.
Values are mean ± variance.
- ALS
- Amyotrophic Lateral Sclerosis
- HC
- Healthy Control
- ALSFRS-R
- ALS Functional Rating Scale-revised
Disease progression rate, (48-ALSFRS-R score)/time from symptom onset.
a
The p value was obtained by Chi-square t-test.
b
The p value was obtained by two-sample t-test.